Krispy Kreme Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 28, 2025 · FY), Krispy Kreme Inc reported revenue of $1.5B (-8.6% year on year).
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Total net revenues | $1.5B | $1.7B | $1.7B | $1.5B |
| Product and distribution costs | $372.6M | $409.2M | $443.2M | $406.2M |
| Operating expenses | $799.0M | $809.9M | $776.6M | $704.3M |
| Selling, general and administrative expense | $226.3M | $274.3M | $266.9M | $223.2M |
| Marketing expenses | $45.1M | $47.7M | $45.9M | $42.6M |
| Goodwill and other asset impairments | $432.4M | — | — | — |
| Pre-opening costs | $3.6M | $3.4M | $4.1M | $4.2M |
| Other income, net | ($24.1M) | ($4.0M) | $10.4M | $10.2M |
| Depreciation and amortization expense | $137.1M | $133.6M | $125.9M | $110.3M |
| Operating (loss)/income | ($469.3M) | ($8.7M) | $13.1M | $29.0M |
| Interest expense, net | $65.8M | $60.1M | — | $34.1M |
| Loss/(gain) on divestiture of Insomnia Cookies | $11.5M | — | — | — |
| Other non-operating (income)/expense, net | ($2.0M) | $1.9M | $3.8M | $3.0M |
| (Loss)/income before income taxes | ($544.6M) | $19.8M | ($41.0M) | ($8.2M) |
| Income tax (benefit)/expense | ($20.8M) | $16.0M | ($4.3M) | $612.0K |
| Net (loss)/income | ($523.8M) | $3.8M | ($36.6M) | ($8.8M) |
| Net (loss)/income attributable to noncontrolling interest | ($8.0M) | $720.0K | $1.3M | $6.8M |
| Net (loss)/income attributable to Krispy Kreme, Inc. | ($515.8M) | $3.1M | ($37.9M) | ($15.6M) |
| Common stock — Basic (in dollars per share) | -$3.04 | $0.02 | -$0.23 | -$0.10 |
| Common stock — Diluted (in dollars per share) | -$3.04 | $0.02 | -$0.23 | -$0.10 |
| Basic (in shares) | 170.9M | 169.3M | 168.3M | 167.5M |
| Diluted (in shares) | 170.9M | 171.5M | 168.3M | 167.5M |
| Line item | Jun 28, 2026 · Q2 | Mar 29, 2026 · Q1 | Sep 28, 2025 · Q3 | Jun 29, 2025 · Q2 |
|---|---|---|---|---|
| Total net revenues | $331.0M | $367.0M | $375.3M | $379.8M |
| Product and distribution costs | $86.0M | $88.3M | $96.2M | $92.6M |
| Operating expenses | $158.9M | $188.1M | $195.9M | $210.7M |
| Selling, general and administrative expense | $53.7M | $58.0M | $49.4M | $62.9M |
| Marketing expenses | $11.1M | $10.1M | $11.8M | $12.2M |
| Pre-opening costs | $0 | $194.0K | $666.0K | $1.5M |
| Goodwill and other asset impairments | $4.2M | $1.9M | $4.8M | $406.9M |
| Gain on refranchising, net | $0 | ($8.9M) | — | — |
| Other income (expense), net | $1.0M | $759.0K | ($9.8M) | ($8.3M) |
| Depreciation and amortization expense | $27.0M | $32.1M | $33.4M | $35.8M |
| Operating loss | ($11.0M) | ($3.6M) | ($7.2M) | ($434.6M) |
| Interest expense, net | $13.4M | $15.6M | $16.4M | $16.7M |
| Loss on divestiture of Insomnia Cookies | $0 | — | — | $11.5M |
| Other non-operating income, net | $261.0K | $159.0K | $591.0K | $1.2M |
| Loss before income taxes | ($24.1M) | ($19.1M) | ($22.9M) | ($461.6M) |
| Income tax expense/(benefit) | ($4.3M) | $3.6M | ($2.8M) | ($20.5M) |
| Net loss | ($19.8M) | ($22.7M) | ($20.1M) | ($441.1M) |
| Net income/(loss) attributable to noncontrolling interest | $480.0K | $111.0K | ($687.0K) | ($5.9M) |
| Net loss attributable to Krispy Kreme, Inc. | ($20.3M) | ($22.8M) | ($19.4M) | ($435.3M) |
| Common stock — Basic (in dollars per share) | -$0.12 | -$0.16 | -$0.11 | -$2.55 |
| Common stock — Diluted (in dollars per share) | -$0.12 | -$0.16 | -$0.11 | -$2.55 |
| Basic (in shares) | 172.6M | 172.0M | 171.2M | 170.8M |
| Diluted (in shares) | 172.6M | 172.0M | 171.2M | 170.8M |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $42.4M | $29.0M | $38.2M | $35.4M |
| Restricted cash | $501.0K | $353.0K | $429.0K | $359.0K |
| Accounts receivable, net | $61.6M | $67.7M | $59.4M | $51.1M |
| Inventories | $26.9M | $28.1M | $34.7M | $46.2M |
| Taxes receivable | $10.9M | $16.2M | $15.5M | $18.3M |
| Current assets held for sale | $13.3M | — | — | — |
| Prepaid expense and other current assets | $18.9M | $31.6M | $25.4M | $27.0M |
| Total current assets | $174.5M | $172.9M | $173.6M | $178.3M |
| Property and equipment, net | $460.9M | $511.1M | $538.2M | $472.4M |
| Goodwill, net | $712.3M | $1.0B | $1.1B | $1.1B |
| Other intangible assets, net | $797.7M | $819.9M | $946.3M | $966.1M |
| Operating lease right of use asset, net | $395.5M | $409.9M | $457.0M | $417.4M |
| Investments in unconsolidated entities | $7.4M | $91.1M | — | — |
| Noncurrent assets held for sale | $31.1M | — | — | — |
| Other assets | $13.6M | $19.5M | $23.5M | $26.5M |
| Total assets | $2.6B | $3.1B | $3.2B | $3.1B |
| Current portion of long-term debt | $66.0M | $56.4M | $54.6M | $40.0M |
| Current operating lease liabilities | $51.2M | $46.6M | $50.4M | $43.2M |
| Accounts payable | $134.4M | $123.3M | $156.5M | $225.3M |
| Accrued liabilities | $99.8M | $124.2M | $134.0M | $104.4M |
| Current liabilities held for sale | $13.5M | — | — | — |
| Structured payables | $92.4M | $135.7M | $130.1M | $103.6M |
| Total current liabilities | $457.3M | $486.2M | $525.6M | $516.5M |
| Long-term debt, less current portion | $911.9M | $844.5M | $836.6M | $739.1M |
| Noncurrent operating lease liabilities | $395.9M | $405.4M | $454.6M | $412.8M |
| Deferred income taxes, net | $96.2M | $130.7M | $123.9M | $143.1M |
| Noncurrent liabilities held for sale | $11.8M | — | — | — |
| Other long-term obligations and deferred credits | $42.9M | $40.8M | $36.1M | $38.3M |
| Total liabilities | $1.9B | $1.9B | $2.0B | $1.8B |
| Redeemable noncontrolling interest | $24.2M | — | — | — |
| Total mezzanine equity | $24.2M | — | — | — |
| Common stock, $0.01 par value; 300,000 shares authorized as of both December 28, 2025 and December 29, 2024; 171,555 and 170,060 shares issued and outstanding as of December 28, 2025 and December 29, 2024, respectively | 1.7M | 1.7M | 1.7M | 1.7M |
| Additional paid-in capital | $1.5B | $1.5B | $1.4B | $1.4B |
| Shareholder note receivable | ($1.8M) | ($1.9M) | ($3.9M) | ($4.8M) |
| Accumulated other comprehensive loss, net of income tax | ($2.1M) | ($32.1M) | $7.2M | ($9.2M) |
| Retained deficit | ($821.4M) | ($299.6M) | ($279.0M) | ($217.5M) |
| Total shareholders’ equity attributable to Krispy Kreme, Inc. | $650.1M | $1.1B | $1.2B | $1.2B |
| Noncontrolling interest | $2.7M | $29.9M | $94.1M | $102.5M |
| Total shareholders’ equity | $652.8M | $1.2B | $1.3B | $1.3B |
| Total liabilities, mezzanine equity, and shareholders’ equity | $2.6B | $3.1B | $3.2B | $3.1B |
| Line item | Jun 28, 2026 | Mar 29, 2026 | Sep 28, 2025 | Jun 29, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $21.8M | $74.2M | $30.7M | $21.3M |
| Restricted cash | $317.0K | $490.0K | $445.0K | $559.0K |
| Accounts receivable, net | $77.4M | $53.5M | $53.8M | $57.3M |
| Inventories | $28.7M | $27.2M | $28.1M | $33.7M |
| Taxes receivable | $14.2M | $11.0M | $19.6M | $18.0M |
| Current assets held for sale | $2.3M | $1.9M | — | — |
| Prepaid expense and other current assets | $20.8M | $18.6M | $29.1M | $23.8M |
| Total current assets | $165.4M | $186.9M | $161.8M | $154.6M |
| Property and equipment, net | $375.7M | $383.3M | $491.3M | $509.4M |
| Goodwill, net | $669.7M | $669.3M | $708.4M | $711.8M |
| Other intangible assets, net | $727.7M | $733.1M | $803.6M | $812.3M |
| Operating lease right of use assets, net | $350.0M | $337.5M | $410.1M | $418.6M |
| Investments in unconsolidated entities | $21.9M | $22.1M | $6.7M | $6.1M |
| Noncurrent assets held for sale | $0 | $0 | — | — |
| Other assets | $52.8M | $54.5M | $18.0M | $17.7M |
| Total assets | $2.4B | $2.4B | $2.6B | $2.6B |
| Current portion of long-term debt | $71.0M | $58.7M | $73.3M | $67.6M |
| Current operating lease liabilities | $47.0M | $44.7M | $47.7M | $47.0M |
| Accounts payable | $148.5M | $130.7M | $116.5M | $97.4M |
| Accrued liabilities | $91.6M | $120.6M | $103.7M | $110.9M |
| Current liabilities held for sale | $0 | $0 | — | — |
| Structured payables | $107.0M | $91.2M | $107.7M | $134.7M |
| Total current liabilities | $465.1M | $446.0M | $448.9M | $457.6M |
| Long-term debt, less current portion | $794.2M | $829.7M | $906.2M | $889.4M |
| Noncurrent operating lease liabilities | $351.0M | $341.3M | $410.5M | $419.4M |
| Deferred income taxes, net | $93.8M | $97.2M | $92.9M | $99.8M |
| Noncurrent liabilities held for sale | $0 | $0 | — | — |
| Other long-term obligations and deferred credits | $39.4M | $39.2M | $47.4M | $46.1M |
| Total liabilities | $1.7B | $1.8B | $1.9B | $1.9B |
| Redeemable noncontrolling interest | $0 | $0 | — | — |
| Total mezzanine equity | $0 | $0 | — | — |
| Common stock, $0.01 par value; 300,000 shares authorized as of both June 28, 2026 and December 28, 2025; 172,744 and 171,555 shares issued and outstanding as of June 28, 2026 and December 28, 2025, respectively | 1.7M | 1.7M | 1.7M | 1.7M |
| Additional paid-in capital | $1.5B | $1.5B | $1.5B | $1.5B |
| Shareholder note receivable | ($1.1M) | ($1.3M) | ($1.8M) | ($1.8M) |
| Accumulated other comprehensive income/(loss), net of income tax | $7.3M | $4.2M | ($9.3M) | ($5.0M) |
| Retained deficit | ($864.5M) | ($844.2M) | ($793.6M) | ($774.2M) |
| Total shareholders’ equity attributable to Krispy Kreme, Inc. | $618.1M | $631.8M | $670.3M | $693.6M |
| Noncontrolling interest | $1.7M | $1.5M | $23.6M | $24.6M |
| Total shareholders’ equity | $619.8M | $633.3M | $693.8M | $718.2M |
| Total liabilities, mezzanine equity, and shareholders’ equity | $2.4B | $2.4B | $2.6B | $2.6B |
| Line item | Dec 28, 2025 · FY | Dec 29, 2024 · FY | Dec 31, 2023 · FY | Jan 1, 2023 · FY |
|---|---|---|---|---|
| Net (loss)/income | ($523.8M) | $3.8M | ($36.6M) | ($8.8M) |
| Depreciation and amortization expense | $137.1M | $133.6M | $125.9M | $110.3M |
| Deferred and other income taxes | ($35.6M) | $3.1M | ($18.5M) | ($14.2M) |
| Goodwill impairment | $356.0M | — | — | — |
| Loss on extinguishment of debt | $0 | $0 | $472.0K | $0 |
| Long-lived asset impairment and lease termination charges | $76.5M | $4.5M | $24.9M | $18.3M |
| Loss on disposal of property and equipment | $1.6M | $1.3M | $110.0K | $393.0K |
| Loss/(gain) on divestiture of Insomnia Cookies | $11.5M | — | — | — |
| Gain on refranchising | ($1.4M) | — | — | — |
| Gain on remeasurement of equity method investment | $0 | ($5.6M) | — | — |
| Gain on sale-leaseback | ($6.7M) | ($1.6M) | ($9.6M) | ($6.5M) |
| Share-based compensation | $12.9M | $35.1M | $24.2M | $18.2M |
| Change in accounts and notes receivable allowances | $1.4M | $646.0K | $654.0K | $570.0K |
| Inventory write-off | $6.3M | $2.8M | $11.2M | $868.0K |
| Settlement of interest rate swap derivatives | $0 | $0 | $7.7M | $8.5M |
| Amortization related to settlement of interest rate swap derivatives | $0 | ($5.9M) | ($10.3M) | — |
| Other | $2.1M | ($619.0K) | $2.2M | $2.2M |
| Accounts, notes, and taxes receivable | $5.5M | ($13.9M) | ($3.5M) | ($9.5M) |
| Inventories | ($19.9M) | ($2.0M) | $780.0K | ($12.5M) |
| Other current and noncurrent assets | ($4.4M) | ($873.0K) | ($2.4M) | ($1.7M) |
| Operating lease assets and liabilities | ($943.0K) | ($1.2M) | $5.1M | ($793.0K) |
| Accounts payable and accrued liabilities | $15.1M | ($20.2M) | ($74.5M) | $32.0M |
| Other long-term obligations and deferred credits | $677.0K | $3.4M | ($2.2M) | $2.6M |
| Net cash provided by operating activities | $33.9M | $45.8M | $45.5M | $139.8M |
| Purchase of property and equipment | ($97.9M) | ($120.8M) | ($121.4M) | ($111.7M) |
| Proceeds from disposals of assets | $3.1M | $183.0K | $218.0K | $1.1M |
| Proceeds from sale-leaseback | $10.9M | $6.3M | $10.0M | $8.4M |
| Acquisition of shops and franchise rights from franchisees, net of cash acquired | $0 | ($31.9M) | $0 | ($17.3M) |
| Purchase of equity method investment | ($3.0M) | ($3.5M) | ($1.4M) | ($989.0K) |
| Net proceeds from divestiture of Insomnia Cookies | $75.0M | $124.1M | — | — |
| Principal payment received from loan to Insomnia Cookies | $0 | $45.0M | — | — |
| Principal payments received from loans to franchisees | $1.2M | $985.0K | $20.0K | $59.0K |
| Disbursement for loan receivable | $1.4M | $1.1M | $0 | $975.0K |
| Net cash (used for)/provided by investing activities | ($12.1M) | $19.3M | ($112.6M) | ($121.5M) |
| Proceeds from the issuance of debt | $778.5M | $676.3M | $1.2B | $149.0M |
| Repayment of long-term debt and lease obligations | ($728.6M) | ($712.8M) | ($1.1B) | ($101.2M) |
| Payment of financing costs | ($825.0K) | $0 | ($5.2M) | $0 |
| Proceeds from structured payables | $291.0M | $376.2M | $241.1M | $282.0M |
| Payments on structured payables | ($334.6M) | ($345.3M) | ($214.6M) | ($294.5M) |
| Payment of contingent consideration related to a business combination | $0 | $0 | ($925.0K) | ($900.0K) |
| Capital contribution from shareholders, net of loans issued | $0 | $919.0K | $764.0K | — |
| Proceeds from sale of noncontrolling interest in subsidiary | $0 | $1.6M | $292.0K | $593.0K |
| Distribution to shareholders | ($11.9M) | ($23.7M) | ($23.6M) | ($23.4M) |
| Payments for repurchase and retirement of common stock | ($1.4M) | ($5.5M) | ($1.9M) | ($4.0M) |
| Distribution to noncontrolling interest | ($36.0K) | ($41.6M) | ($15.5M) | ($11.7M) |
| Line item | Jun 28, 2026 · YTD | Mar 29, 2026 · Q1 | Sep 28, 2025 · YTD | Jun 29, 2025 · YTD |
|---|---|---|---|---|
| Net loss | ($42.5M) | ($22.7M) | ($494.7M) | ($474.5M) |
| Depreciation and amortization expense | $59.1M | $32.1M | $103.1M | $69.7M |
| Deferred and other income taxes | ($5.0M) | ($709.0K) | ($37.4M) | ($30.8M) |
| Goodwill impairment | $0 | — | $356.0M | $356.0M |
| Other asset impairments and lease termination charges | $6.1M | $1.9M | $55.9M | $51.1M |
| Loss on disposal of property and equipment | $1.4M | $458.0K | $1.5M | $403.0K |
| Loss on divestiture of Insomnia Cookies | $0 | — | — | $11.5M |
| Gain on refranchising, net | ($8.9M) | — | — | — |
| Gain on acquisition of equity method investment | ($416.0K) | — | $0 | — |
| Gain on sale-leaseback | $0 | — | ($6.7M) | ($6.7M) |
| Share-based compensation | $7.9M | $4.6M | $8.0M | $7.2M |
| Change in accounts and notes receivable allowances | $3.3M | $434.0K | $1.1M | $986.0K |
| Inventory write-off | ($4.0K) | ($14.0K) | $6.4M | $1.5M |
| Other | ($128.0K) | $533.0K | $317.0K | $2.2M |
| Increase (Decrease) in Accounts Receivable | ($27.7M) | — | — | — |
| Increase (Decrease) in Inventories | ($7.0M) | — | — | — |
| Increase (Decrease) in Accounts Payable | $41.0K | — | — | — |
| Increase (Decrease) in Other Current Assets and Liabilities, Net | $36.5M | — | — | — |
| Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | ($6.3M) | — | — | — |
| Increase (Decrease) in Accrued Liabilities | $4.1M | — | — | — |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | ($10.7M) | — | — | — |
| Net cash provided by/(used for) operating activities | $10.0M | $20.2M | ($11.1M) | ($53.4M) |
| Purchase of property and equipment | ($16.1M) | ($8.8M) | ($80.8M) | ($54.1M) |
| Proceeds from disposals of assets | $252.0K | $24.0K | — | — |
| Proceeds from sale-leaseback | $0 | — | $10.9M | $10.9M |
| Net proceeds from refranchising transactions | $111.4M | $111.4M | $75.0M | $75.0M |
| Purchase/proceeds of equity method investment | $129.0K | — | — | — |
| Purchase of minority interests | ($2.6M) | ($2.6M) | — | — |
| Net proceeds from divestiture of Insomnia Cookies | $0 | — | — | — |
| Principal payments received from loans to franchisees | $0 | — | $1.2M | $1.2M |
| Purchase of redeemable noncontrolling interest | ($25.1M) | — | $0 | $0 |
| Other investing activities | $0 | $0 | $177.0K | $99.0K |
| Net cash provided by/(used for) investing activities | $68.0M | $100.1M | $3.4M | $30.9M |
| Proceeds from the issuance of debt | $120.8M | $72.8M | $661.0M | $516.9M |
| Repayment of long-term debt and lease obligations | ($234.2M) | ($159.7M) | ($606.6M) | ($485.9M) |
| Payment of financing costs | $0 | — | ($825.0K) | ($825.0K) |
| Proceeds from structured payables | $118.6M | $57.4M | $242.3M | $198.1M |
| Payments on structured payables | ($104.1M) | ($58.6M) | ($270.4M) | ($199.2M) |
| Capital contribution by shareholders, net of loans issued | $262.0K | $130.0K | $0 | $0 |
| Distribution to shareholders | $0 | $0 | ($11.9M) | ($11.9M) |
| Payments for repurchase and retirement of common stock | ($527.0K) | ($402.0K) | ($1.2M) | ($787.0K) |
| Distribution to noncontrolling interest | $219.0K | $350.0K | ($36.0K) | ($36.0K) |
| Net cash provided by/(used for) financing activities | ($98.9M) | ($88.1M) | $12.4M | $16.2M |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | $203.0K | ($297.0K) | ($2.9M) | ($1.3M) |
| Net decrease in cash, cash equivalents and restricted cash | ($20.7M) | $31.8M | $1.8M | ($7.5M) |
Krispy Kreme Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.